April 30, 2008 SkyePharma Announces Flutiform(TM) Phase III Efficacy Study Meets Primary Endpoints April 22, 2008 SkyePharma Announces Exclusive License Agreement with Kyorin for Development and Distribution of Flutiform in Japan April 15, 2008 SkyePharma Announces Positive Results of Flutiform Paediatric Study